ARDT (Ardent Health, Inc.) Stock Analysis - SEC Filings

Ardent Health, Inc. (ARDT) is a publicly traded Healthcare sector company. As of May 21, 2026, ARDT trades at $9.45 with a market cap of $1.45B and a P/E ratio of 9.87. ARDT moved -3.57% today. Year to date, ARDT is +5.70%; over the trailing twelve months it is -37.54%. Its 52-week range spans $8.07 to $20.72. Analyst consensus is buy with an average price target of $12.59. Rallies surfaces ARDT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find ARDT SEC filings?

Rallies organizes ARDT SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

ARDT Key Metrics

Key financial metrics for ARDT
MetricValue
Price$9.45
Market Cap$1.45B
P/E Ratio9.87
EPS$0.96
Dividend Yield0.00%
52-Week High$20.72
52-Week Low$8.07
Volume10
Avg Volume0
Revenue (TTM)$6.32B
Net Income$230.13M
Gross Margin0.00%

Latest ARDT News

Recent ARDT Insider Trades

  • Webb Robert Thomas bought 10.00K (~$174.70K) on Nov 8, 2024.
  • Webb Robert Thomas bought 10.00K (~$164.90K) on Nov 8, 2024.

ARDT Analyst Consensus

10 analysts cover ARDT: 0 strong buy, 6 buy, 3 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $12.59.

Common questions about ARDT

Where can I find ARDT SEC filings?
Rallies organizes ARDT SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show ARDT 10-K and 10-Q filings?
Rallies organizes ARDT SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is ARDT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ARDT. It does not provide personalized investment advice.
ARDT

ARDT